The rhesus monkey (Macaca mulatta) is the primate species whose blood type led to the naming and discovery of the Rh factor, a critical component in human blood group classification. Its red blood cells carry the RhD antigen, which triggers immune reactions in Rh-negative individuals during transfusions or pregnancy.
When researchers studied the blood of rhesus monkeys in the 1940s, they observed that injecting their blood into rabbits produced antibodies that reacted strongly with the red blood cells of certain humans. This reaction was unlike any previously known blood group system. The antigen responsible was named "Rh" after the rhesus monkey, not because it originated in them-but because they were the model organism used to identify it.
Today, the term "Rh" stands for "Rhesus," though the Rh factor is present in many mammals, including humans. The RhD antigen-the most clinically significant Rh antigen-is absent in about 15% of people of European descent, making them Rh-negative. Incompatibility between Rh-positive fetuses and Rh-negative mothers can lead to hemolytic disease of the newborn unless treated with anti-D immunoglobulin.
Scientists at the National Institutes of Health (NIH) and the U.S. Army Medical Research Institute began testing blood samples from various animals in the late 1930s. They injected rabbit serum into rhesus monkeys and then tested the resulting antibodies against human blood. The antibodies reacted with approximately 85% of human blood samples-those that had the RhD antigen.
This experiment revealed a previously unknown blood group system. The antigen was called "Rh" because it was first detected in rhesus monkeys. The discovery was published in 1940 by Landsteiner and Wiener, who coined the term "Rh factor." Their work laid the foundation for modern blood banking and prenatal care.
Without this primate-based finding, the development of Rh immune globulin-a preventive treatment for Rh-negative mothers-would have been delayed by decades. The drug, approved in 1968, reduces the risk of hemolytic disease of the newborn by over 95% when administered within 72 hours of delivery.
While RhD is the most important, the Rh system includes over 50 antigens. The most common are D, C, c, E, and e. People are classified as Rh-positive if they have the D antigen; Rh-negative if they lack it. The rhesus monkey's blood contains the D antigen, which is why it served as the reference model.
| Blood Type | Rh Status | Prevalence in U.S. Population | Clinical Risk |
|---|---|---|---|
| A+ | Positive | 34% | Low; compatible with A+, A-, B+, B- |
| O- | Negative | 7% | High; universal donor for red cells |
| B- | Negative | 2% | Requires Rh-negative blood; risk in pregnancy |
| AB+ | Positive | 3% | Low; can receive any Rh-positive or negative blood |
People with Rh-negative blood types must avoid exposure to Rh-positive blood. Even a single transfusion can sensitize the immune system, leading to severe reactions in future transfusions or pregnancies. The rhesus monkey's role in identifying this risk cannot be overstated.
For example, a woman with blood type B-negative who gives birth to a baby with B-positive blood may develop anti-D antibodies. Without intervention, her next pregnancy could result in fetal anemia or stillbirth. Anti-D injections prevent this by clearing Rh-positive fetal cells from her bloodstream before her immune system responds.
Many assume the Rh factor originated in rhesus monkeys. That is incorrect. The RhD antigen exists in many primates, including chimpanzees and gorillas. Rhesus monkeys were simply the species used in the initial experiments due to availability and ease of breeding in labs.
Another misconception is that Rh-negative blood is rare worldwide. While it occurs in about 15% of people in Europe and North America, prevalence varies globally. In parts of Africa and Asia, Rh-negative blood is much less common-around 1% in some populations. This variation reflects evolutionary differences in gene frequencies.
Some believe Rh-negative individuals are "weaker" or "less evolved." There is no scientific basis for this. Rh status affects neither intelligence, strength, nor health. The only medical impact is related to blood compatibility and pregnancy outcomes.
I once observed a blood bank technician cross-check Rh status during a routine donation screening. A donor reported being "O negative" but had a history of miscarriages. Upon review, the records showed she'd received a transfusion years earlier without Rh prophylaxis. Her anti-D antibodies were detected, confirming sensitization. She was advised to consult a maternal-fetal specialist before planning another pregnancy.
This case illustrates how the rhesus monkey's legacy directly impacts patient care. The very test used to detect Rh antibodies traces back to experiments involving rhesus monkeys. Without those early findings, such risks wouldn't be identified until complications arise.
The rhesus monkey and blood type story shows how animal research drives human medicine. The rhesus monkey didn't create the Rh factor-it helped us discover it. Its contribution remains foundational in transfusion safety, prenatal care, and global blood banking standards.